Previous 10 | Next 10 |
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings rel...
There are more than 3,000 active patient organizations across the U.S., supporting patients through their health journeys and shaping research and care delivery Patient organizations are assuming an ever-expanding role, including developing patient registries to better understand diseases...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a strategic collaboration with argenx to advance treatment to patients with rare autoimmune diseases through innovative ...
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & ...
2023-09-24 23:18:43 ET Summary William Nygren's 13F portfolio value increased from $55.60B to $56.60B this quarter. The portfolio is diversified with around 200 positions, with the largest five stakes being Alphabet, Capital One Financial, Amazon.com, Charter Communications, and F...
2023-09-21 17:32:46 ET Summary Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 million and GAAP net income increasing 23%. Vee...
IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, has been named a Leader in the IDC Marketscape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment. Fueled by IQVIA Connected Inte...
2023-09-12 08:17:06 ET More on ANI Pharma Seeking Alpha’s Quant Rating on ANI Pharmaceuticals Historical earnings data for ANI Pharmaceuticals Financial information for ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharm...
2023-09-10 15:17:31 ET HSBC initiated coverage of 11 US biopharma stocks this week, adding IQVIA, Zoetis, bluebird and Actinium Pharmaceuticals to its “buy” ratings list. IQVIA ( NYSE: IQV ) and Zoetis ( NYSE: ZTS ) were labeled “quality growthȁ...
2023-09-08 00:03:09 ET Summary The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...